Arkolith/Insider Trading/COLL/Form 4

Dreyer Scott

EVP & Chief Commercial OfficerCOLLEGIUM PHARMACEUTICAL, INC (COLL) · full profile →Form 4 · filed Feb 12, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 10, 2026Tax withholding(F)22K$46.75$1.0M122K
Feb 10, 2026Tax withholding(F)10K$46.75$466K143K
Feb 10, 2026Grant(A)31K—$0153K
Feb 10, 2026Grant(A)19K—$0123K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001746251-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML